Literature DB >> 11356430

Dehydroepiandrosterone replacement for patients with adrenal insufficiency.

J C Achermann1, B L Silverman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11356430     DOI： 10.1016/S0140-6736(00)04617-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses.

Authors:  S Laureti; A Falorni; F Santeusanio
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

2.  No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison's Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions.

Authors:  Adrian H Heald; Andreas Walther; Julian R E Davis; Gabriela Y C Moreno; John Kane; Mark Livingston; Helen L Fowler
Journal:  Front Psychol       Date:  2017-05-11

3.  Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve?

Authors:  Albertus Beishuizen; Lambertus G Thijs; István Vermes
Journal:  Crit Care       Date:  2002-07-09       Impact factor: 9.097

Review 4.  Dehydroepiandrosterone and Erectile Function: A Review.

Authors:  Ahmed I El-Sakka
Journal:  World J Mens Health       Date:  2018-05-11       Impact factor: 5.400
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.